Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-051051 and itraconazole drug-drug interaction study in healthy Japanese adults
jRCT2031260447Phase 1Active, not recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of JTE-051 and itraconazole in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS), sponsored by Shionogi & Co., Ltd. Primary endpoint: Plasma drug concentrations. Started Sep 2026; status: active, not recruiting.
02
Drugs
JTE-051itraconazole
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on jRCT2031260447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260447.